Acticor Biotech SAS
ALACT.PA News Today: Stay Updated with the Latest Acticor Biotech SAS News in Real Time
Find ALACT.PA news now at Meyka AI. Stay informed with the latest Acticor Biotech SAS stocks updates, including price news, market analysis, and expert insights.

Volume spike lifts QPTFF Quest PharmaTech (PNK) $0.03 Apr 04 2026: follow-up
QPTFF stock sees a volume surge to 225,625 shares on Apr 04 2026; short-term momentum and risks outlined

ITRM Iterum Therapeutics plc NASDAQ Q4 2025 results 03 Apr 2026: Earnings drivers and outlook
ITRM stock closed at $0.03 on 03 Apr 2026 after Q4 2025 results. Read Meyka AI earnings spotlight and short-term outlook for ITRM stock

4564.T OncoTherapy Science JPX +9.09% to JPY 24.00 on 03 Apr 2026: volume surge signals clinical interest
4564.T stock jumps to JPY 24.00 on 03 Apr 2026 with heavy volume; analysis, grade and forecast from Meyka AI

CHM.CN Waverunner Capital Inc. CNQ 03 Apr 2026: C$0.05 after 900% jump, monitor liquidity
CHM.CN stock update: price C$0.05 after 900% jump, market cap CAD 37,211,650.00. Trading, valuation and forecast insights

PHASQ falls 99.00% to $0.000001 on 03 Apr 2026: immediate liquidity risk
PHASQ stock fell 99.00% to $0.000001 on 03 Apr 2026; Meyka AI explains drivers, liquidity, and forecast for investors

Earnings 06 Apr: GeNeuro GNRO.PA EURONEXT pre-market 03 Apr 2026: readout risk
GNRO.PA stock pre-market update ahead of 06 Apr earnings; clinical readout may move price, forecast and Meyka AI grade included

Pre-market top loser: CDW Holding (BXE.SI) -7.53% to S$0.086: key support S$0.07
BXE.SI stock falls to S$0.086 in pre-market; Meyka AI forecast shows downside to S$0.06 quarterly. Read the analysis and price targets

BTIG Maintains ALDX (Aldeyra Therapeutics) at Buy on Mar 17, 2026
BTIG maintains Buy on ALDX; ALDX analyst rating reviewed after Mar 17, 2026 note

FYB.DE Formycon XETRA intraday +5.33% 02 Apr 2026: earnings 15:30 key catalyst
FYB.DE stock jumps intraday; earnings due 02 Apr 2026 at 15:30 may move price β Meyka AI analysis and forecast